文献速递头颈外科

p16阳性口咽癌术后淋巴结状态的预后意义

Prognostic Significance of Lymph Node Status in p16+ Oropharyngeal Cancer After Surgical Treatment.
PubMed 文献 · Laryngoscope · 2020-04-13

多因素分析显示仅对侧淋巴结转移与无复发生存期(RFS)显著相关;无对侧淋巴结转移者5年RFS为92.4%,有对侧淋巴结转移者为68.8%。

要点

  • p16阳性口咽癌术后病理淋巴结状态中,仅对侧淋巴结转移与复发显著相关。
  • 无对侧淋巴结转移者5年RFS为92.4%,有对侧淋巴结转移者为68.8%。
  • 转移淋巴结数目和淋巴结比率在本研究中未显示显著预后意义。

核心结论

  • 在p16阳性口咽癌的病理淋巴结状态中,仅对侧淋巴结转移对疾病复发具有预后意义。

研究设计与样本

  • 原发肿瘤部位为扁桃体160例、舌根24例、软腭4例。

主要发现

  • 多因素分析中仅无复发生存期(RFS)与对侧淋巴结转移显著相关。
  • Kaplan-Meier分析显示,无对侧淋巴结转移患者5年RFS为92.4%,有对侧淋巴结转移患者为68.8%。

关键数值与推荐

  • 无对侧淋巴结转移者5年RFS为92.4%,有对侧淋巴结转移者5年RFS为68.8%。

临床怎么用

  • 对于p16阳性口咽癌术后患者,应关注对侧淋巴结转移状态以评估复发风险。

局限性

  • 本研究为回顾性病例系列,证据等级为4级。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVES/HYPOTHESIS: In this study, we retrospectively reviewed medical records of patients who underwent surgery for p16+ oropharyngeal cancer and analyzed the prognostic implications of pathologic lymph node (LN) status, including number of metastatic LNs, LN ratio, and location of metastatic LNs. STUDY DESIGN: Retrospective case series. METHODS: We retrospectively reviewed data on patients diagnosed with p16+ oropharyngeal cancer. RESULTS: The study population consisted of 159 males and 29 females with a mean age of 57.2 years. The primary tumor sites were tonsils (n = 160), base of the tongue (n = 24), and soft palate (n = 4). Only recurrence-free survival (RFS) showed a significant correlation with contralateral LN metastasis on multivariate analysis. On Kaplan-Meier analysis, 5-year RFS was 92.4% in patients without contralateral LN metastasis and 68.8% in patients with contralateral LN metastasis. CONCLUSIONS: Among pathologic LN status in p16+ oropharyngeal cancer, only contralateral LN metastasis showed prognostic significance in disease recurrence of p16+ oropharyngeal squamous cell carcinoma patients. LEVEL OF EVIDENCE: 4 Laryngoscope, 130: 1973-1979, 2020.

来源:Laryngoscope,查看原文。版权归原作者所有。

引用

  1. Park YM, Eo TS, Koh YW, et al. Prognostic Significance of Lymph Node Status in p16+ Oropharyngeal Cancer After Surgical Treatment. Laryngoscope. 2020. PMID: 32282081. doi:10.1002/lary.28665

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。